Iacta Alea Est: The Inexorable Advance of Tofacitinib in the Treatment of Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. A Case Report

• Auteurs principaux: Walter Conca (Auteur), Ihab Weheba (Auteur), Mohei-Eldin Abouzied (Auteur), Abeer Abdelsayed (Auteur), Yousif Aleyouni (Auteur), Eid Al‐Mutairy (Auteur), Nasir Bakshi (Auteur), Mohammad Khalid (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2020-12-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Rapidly progressive interstitial lung disease is typically associated with clinically amyopathic dermatomyositis and the anti-melanoma differentiation associated gene 5 antibody, a condition with high mortality and resistance to classic immunosuppression. Recent reports have described the efficacy o...